Toxicity of beauvericin on porcine oocyte maturation and preimplantation embryo development

被引:36
作者
Schoevers, Eric J. [1 ]
Santos, Regiane R. [2 ]
Fink-Gremmels, Johanna [2 ]
Roelen, Bernard A. J. [1 ]
机构
[1] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Yalelaan 104, NL-3584 CM Utrecht, Netherlands
[2] Univ Utrecht, Fac Vet Med, Inst Risk Assessment Sci, Div Vet Pharmacol Pharmacotherapy & Toxicol, Yalelaan 104, NL-3584 CM Utrecht, Netherlands
关键词
Pig; Mycotoxin; Beauvericin; Oocyte; Preimplantation embryo; IN-VITRO MATURATION; FOLLICLE-STIMULATING-HORMONE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; REPRODUCTIVE TOXICOLOGY; ABC TRANSPORTER; CYTOCHROME-C; CHO-K1; CELLS; PIG OOCYTES; MYCOTOXINS;
D O I
10.1016/j.reprotox.2016.07.017
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Beauvericin (BEA) is one of many toxins produced by Fusarium species that contaminate feed materials. The aim of this study was to assess its effects on porcine oocyte maturation and preimplantation embryo development. Cumulus-oocyte-complexes and developing embryos were exposed to BEA and cultured until the blastocyst stage. Cumulus cells, oocytes and embryos were examined for viability, progesterone synthesis, multidrug resistance protein (MDR1), ATP content and gene expression related to MDR1 function, oxidative phosphorylation, steroidogenesis and apoptosis. BEA was toxic in embryos, oocytes and cumulus cells at concentrations exceeding 0.5 mu M, and embryos were most vulnerable after the four-cell stage. Since BEA exerted different effects in embryos, oocytes and cumulus cells, the toxic mechanism is suggested to involve different pathways. Currently there are no consistent data on adverse effects of BEA in pig farms. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:159 / 169
页数:11
相关论文
共 64 条
[51]   Multi-Mycotoxin Screening Reveals the Occurrence of 139 Different Secondary Metabolites in Feed and Feed Ingredients [J].
Streit, Elisabeth ;
Schwab, Christina ;
Sulyok, Michael ;
Naehrer, Karin ;
Krska, Rudolf ;
Schatzmayr, Gerd .
TOXINS, 2013, 5 (03) :504-523
[52]  
SUN FZ, 1992, DEVELOPMENT, V115, P947
[53]   Use of energy substrates by various stage preimplantation pig embryos produced in vivo and in vitro [J].
Swain, JE ;
Bormann, CL ;
Clark, SG ;
Walters, EA ;
Wheeler, MB ;
Krisher, RL .
REPRODUCTION, 2002, 123 (02) :253-260
[54]   Beauvericin activates Ca2+-activated Cl- currents and induces cell deaths in Xenopus oocytes via influx of extracellular Ca2+ [J].
Tang, CY ;
Chen, YW ;
Jow, GM ;
Chou, CJ ;
Jeng, CJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (05) :825-833
[55]   Effect of cryopreservation on the cellular integrity of equine embryos [J].
Tharasanit, T ;
Colenbrander, B ;
Stout, TAE .
REPRODUCTION, 2005, 129 (06) :789-798
[56]   In vivo and in vitro effects of the mycotoxins zearalenone and deoxynivalenol on different non-reproductive and reproductive organs in female pigs:: A review [J].
Tiemann, U. ;
Daenicke, S. .
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2007, 24 (03) :306-314
[57]   The Fusarium mycotoxins enniatins and beauvericin cause mitochondrial dysfunction by affecting the mitochondrial volume regulation, oxidative phosphorylation and ion homeostasis [J].
Tonshin, Anton A. ;
Teplova, Vera V. ;
Andersson, Maria A. ;
Salkinoja-Salonen, Mirja S. .
TOXICOLOGY, 2010, 276 (01) :49-57
[58]   Effects of different reproduction techniques: AI, MOET or IVP, on health and welfare of bovine offspring [J].
van Wagtendonk-de Leeuw, AM ;
Mullaart, E ;
de Roos, APW ;
Merton, JS ;
den Daas, JHG ;
Kemp, B ;
de Ruigh, L .
THERIOGENOLOGY, 2000, 53 (02) :575-597
[59]   The bovine oocyte in vitro maturation model: A potential tool for reproductive toxicology screening [J].
van Woudenberg, Anna Beker ;
Grollers-Mulderij, Mariska ;
Snel, Cor ;
Jeurissen, Nelleke ;
Stierum, Rob ;
Wolterbeek, Andre .
REPRODUCTIVE TOXICOLOGY, 2012, 34 (02) :251-260
[60]   P-glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil [J].
Verschraagen, M ;
Koks, CHW ;
Schellens, JHM ;
Beijnen, JH .
PHARMACOLOGICAL RESEARCH, 1999, 40 (04) :301-306